AFWM
PACB icon

Abich Financial Wealth Management’s Pacific Biosciences PACB Stock Holding History

Abich Financial Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$7.77K Buy
4,573
+3,406
+292% +$5.6K 0.02% 222
2024
Q2 		$1.6K Buy
1,167
+1,104
+1,752% +$2.23K ﹤0.01% 521
2024
Q1 		$236 Buy
+63
New +$369 ﹤0.01% 472

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Abich Financial Wealth Management's PACB Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Pacific Biosciences (PACB) stake by 292% in Q3 2024, buying an estimated $5.6K and bringing the position to 4,573 shares worth $7.77K. The position accounts for 0.02% of the portfolio, ranked #222.

Abich Financial Wealth Management first reported a position in PACB in Q1 2024 and has held it in 3 quarters since. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

  • Abich Financial Wealth Management held 4,573 shares of Pacific Biosciences worth $7.77K as of Q3 2024.
  • Abich Financial Wealth Management bought 3,406 Pacific Biosciences shares in Q3 2024, an estimated $5.6K.
  • Pacific Biosciences made up 0.02% of Abich Financial Wealth Management's portfolio in Q3 2024, its #222 holding.
  • Abich Financial Wealth Management first reported a position in Pacific Biosciences in Q1 2024 and has held it in 3 quarters since.
  • 226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.